Skip to Main Content

Paper Details

Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death.
Eur Heart J
52
2022
/SLC4A3, ANK2, CALM1, CALM2, CALM3, CASQ2, CPVT, Catecholaminergic polymorphic ventricular tachycardia, Channelopathy, KCNH2, KCNJ2, KCNQ1, PKP2, RYR2, SCN5A, SLC4A3, SQTS, SQTS genes, TECRL, TRDN, inherited arrhythmogenic disorders, patients, short QT syndrome, sudden arrhythmic death, sudden death
Author NameAffiliation
Roddy WalshUniversity of Amsterdam
Francesco MazzarottoDepartment of Experimental and Clinical Medicine, University of Florence
Francesco MazzarottoCardiovascular Research Centre, Royal Brompton & Harefield Hospitals
Francesco MazzarottoNational Heart & Lung Institute, Imperial College London
Marco V PerezStanford University
Amy C SturmGeisinger Genomic Medicine Institute
James S WareNational Heart & Lung Institute, Imperial College London
James S WareCardiovascular Research Centre, Royal Brompton & Harefield Hospitals
James S WareMRC London Institute of Medical Sciences, Imperial College London
  • 1 - 9

Datasets

Release 1.2